News
Investor's Business Daily on MSN32m
Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock PriceNovo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition.
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback